Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.

It is evolutionarily certain that we will have more outbreaks, more pandemics, and frankly, they could be significantly worse than Covid,” says global health expert Seth Berkley.

The upcoming EU Biotech Act may be more prominently focused on health. But it will also significantly impact food and food ...

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

The agency will no longer require studies comparing copycat biologics to their branded counterparts, which could help ...

The U.S. Food and Drug Administration is preparing to accelerate approvals for biosimilars, or generic versions of complex ...

The findings reveal that LNPs come in a surprising variety of configurations and the differences correlate with their ...

A review of recent literature shows bioengineering is reshaping oncology, from synthetic biology to nanomedicine, but what's ...

Something unusual is happening to biotech stocks: They’re going up. A drug-pricing deal between Pfizer and the White House and a spate of deals have sent the SPDR S&P Biotech exchange-traded fund up 9 ...

Here's a look at what the Schoonmaker has in common with the Edmund Fitzgerald. The Schoonmaker now sits as part of Toledo's National Museum of the Great Lakes. Over 140,000 bottles of cholesterol ...

After first introducing the M4 chip in May 2024, Apple is ready to move on to the newly announced M5. And, as customers have been led to expect when Apple moves one of its offerings from one number to ...

(Reuters) -U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda Pharmaceutical, deepening their use of artificial intelligence ...